re: Ann: Clinuvel commences US Phase III tria... moveonup,
- cash situation continues to create an overhang on the share price...many are still on the sidelines until that's ironed out.
- Will this be another year of promises on updates on cuv9900 that aren't delievered on? Wouldn't surprise me. In August, it will be the 2-year anniversary that we were first told about this new compound, but after all this time, they still haven't started trials on it or given us a clearer indication of what is going on with it
- EPP will get approved, but keep in mind when Wolgen took over 6.5 years ago, the share price was in the low .30s (over $3 in today's 10:1 share price consolidation "stuff") and yet analyst Stanton's price projection would only have the share price slightly above the share price (adjusted for the 10:1 consolidation) when Wolgen took over many moons ago. That's pathetic.
I'm looking forward to 2013 when we get a definite FDA decision date for EPP. Frustrating that we probably won't get a hard decision date from the European regulators.
re: Ann: Clinuvel commences US Phase III tria... moveonup,- cash...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.12 |
Change
0.250(1.80%) |
Mkt cap ! $706.8M | |||
| Open | High | Low | Value | Volume |
| $13.90 | $14.17 | $13.90 | $675.2K | 48.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 293 | $14.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.12 | 261 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| CUV (ASX) Chart |